China SXT Pharmaceuticals, Inc. SEC filings SXTC
China SXT Pharmaceuticals, Inc. has 169 filings in SEC EDGAR's recent list, going back to Dec 4, 2017. Its latest annual report, Form 20-F, was filed on Jul 1, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 16, 2026 | — |
| EFFECT | Filing | Nov 14, 2025 | — |
| EFFECT | Filing | Nov 4, 2024 | — |
| CORRESP | Letter to the SEC | Nov 1, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 30, 2024 | — |
| NT 20-F | Notification of late filing | Jul 31, 2024 | Mar 31, 2024 |
| UPLOAD | Letter from the SEC | Jun 2, 2023 | — |
| CORRESP | Letter to the SEC | Apr 13, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2023 | — |
| NT 20-F | Notification of late filing | Aug 2, 2021 | Mar 31, 2021 |
| EFFECT | Filing | Feb 10, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2021 | — |
| CORRESP | Letter to the SEC | Feb 9, 2021 | — |
| NT 20-F | Notification of late filing | Jul 31, 2019 | Mar 31, 2019 |
| EFFECT | Filing | Jun 27, 2019 | — |
| CORRESP | Letter to the SEC | Jun 25, 2019 | — |
| CORRESP | Letter to the SEC | Jun 21, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 13, 2019 | — |
| CERT | Filing | Jan 2, 2019 | — |
| 8-A12B | Filing | Dec 26, 2018 | — |
| EFFECT | Filing | Sep 28, 2018 | — |
| CORRESP | Letter to the SEC | Sep 26, 2018 | — |
| CORRESP | Letter to the SEC | Sep 26, 2018 | — |
| CORRESP | Letter to the SEC | Sep 17, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2018 | — |
| CORRESP | Letter to the SEC | May 7, 2018 | — |
| UPLOAD | Letter from the SEC | May 1, 2018 | — |
| CORRESP | Letter to the SEC | Apr 20, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2018 | — |
| CORRESP | Letter to the SEC | Mar 28, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2018 | — |
| CORRESP | Letter to the SEC | Mar 6, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2018 | — |
| CORRESP | Letter to the SEC | Jan 19, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2018 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SXTC (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Virgin Islands, British
- Headquarters
- Taizhou
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1723980
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.